MIRM - CIK 0001759425
Mirum Pharmaceuticals, Inc. (MIRM) reported revenue of $521.31M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $521.31M | +54.7% |
| FY 2024 | $336.89M | +80.8% |
| FY 2023 | $186.37M | +141.8% |
| FY 2022 | $77.06M | +302.7% |
| FY 2021 | $19.14M | - |
| FY 2020 | $0.00 | - |
Mirum Pharmaceuticals, Inc. (MIRM) reported revenue of $521.31M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Mirum Pharmaceuticals, Inc.'s revenue grew from $0.00 to $521.31M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.